Dispensary of Hope Earns NABP Drug Distributor Reaccreditation  PR Newswire

Boston Institute of Biotechnology, LLC with BiBo Pharma Announce Groundbreaking Expansion to Revolutionize Global Biologics Production Capacity  PR Newswire

Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)  PR Newswire

Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection  PR Newswire

Forbes Recognizes Kroger as a Leader in Workplace Culture and Pharmacy Customer Service  PR Newswire

FDA APPROVES ACETADOTE® sNDA  PR Newswire

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area  PR Newswire

Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group  PR Newswire

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting  PR Newswire

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval  PR Newswire

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split  PR Newswire

Genpact Announces Renewed Partnership with Ferring Pharmaceuticals  PR Newswire

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference  PR Newswire

Samsung Biologics signs manufacturing deal with European pharmaceutical company  PR Newswire

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering  PR Newswire

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America  PR Newswire

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors  PR Newswire

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results  PR Newswire

Ionis to present at upcoming investor conferences  PR Newswire

CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY  PR Newswire

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome  PR Newswire

Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results  PR Newswire

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results  PR Newswire

Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement  PR Newswire

Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics  PR Newswire

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)  PR Newswire

West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend  PR Newswire

Children's Hospital of Philadelphia Leader in Sickle Cell Disease Elected to National Academy of Medicine  PR Newswire

Astellas' VYLOY™ (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer  PR Newswire